Related Experiment Video
Updated: Jul 5, 2025

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Longitudinal single cell atlas identifies complex temporal relationship between type I interferon response and
Quy Xiao Xuan Lin1, Deepa Rajagopalan1, Akshamal M Gamage2
1Laboratory of Systems Biology and Data Analytics, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, 138672, Singapore.
Early type I interferon response in COVID-19 patients predicts symptom worsening, but this signature is transient. Severe COVID-19 shows deficient interferon activity and increased SOCS3, a potential therapeutic target.
Area of Science:
- Immunology
- Virology
- Genomics
Background:
- Longitudinal molecular studies of early COVID-19 host response are limited.
- Understanding the dynamics of immune cell states during infection is crucial.
Purpose of the Study:
- To investigate the longitudinal host response in early COVID-19 using single-cell RNA sequencing.
- To identify molecular signatures associated with disease progression and severity.
Main Methods:
- Longitudinal single-cell RNA sequencing on blood samples from 108 COVID-19 patients.
- Analysis of discrete cell subtypes and continuous cell states.
- Validation in independent cohorts and in vitro experiments.
Main Results:
- Upregulation of type I interferon-stimulated genes (ISGs) early in infection predicts symptom worsening.
- ISG expression is dynamic in progressors, peaking early and then declining.
- Severe COVID-19 is characterized by deficient ISG expression and elevated SOCS3, which inhibits SARS-CoV-2 replication in vitro.
Conclusions:
- The type I interferon response in COVID-19 is complex and dynamic.
- Early ISG upregulation is a marker of subsequent symptom worsening.
- SOCS3 is a potential target for host-directed COVID-19 therapies.
More Related Videos
08:26Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024